Lesson 25: Reoviridae Flashcards
The family Reoviridae derives its name from the prototype virus which was
known as the
Respiratory enteric orphan virus
Virus in the family reoviridae are icosahedral, 60 to 80nm in diameter, nonenveloped and possess a layered capsid which is composed of concentric
protein shells.
The genome of reoviruses is composed of ten to twelve segments of doublestranded RNA.
Replication takes place with the cytoplasm of the host cell often with the
formation of intracytoplasmic inclusions.
They are originally isolated from respiratory and enteric sources without any
clinical condition and were thus named orphan.
are arthropod-borne viruses that cause African horse
sickness in horses and blue tongue in sheep and in other domestic and
wild ruminants
Orbivirus members
causes enteritis in neonatal farm animals
Rotavirus
causes arthritis and tenosynovitis in poultry
Orthoreovirus
primarily infect rodents and human
but occasionally cause clinical disease in domestic animals
Coltivirus (Colorado tick fever virus)
Reoviruses are moderately resistant to heat, organic solvents and non-ionic
detergents.
Orthoreoviruses and rotaviruses are stable over a wide range of pH values while
orbiviruses lose infectivity at low pH values
This disease is a non-contagious viral disease of sheep and other domestic and
wild ruminants caused by serotypes of bluetongue virus (BTV) in the genus
orbivirus of the family Reoviridae.
BLUETONGUE
There are 26 serotypes known, with each strain having variable disease severity.
BTV-25, 26 and 27 spread exclusively through vector-independent routes,
potentially causing persistent goat infections.
In endemic areas, infection of cattle is common and usually inapparent. The
viraemia in cattle commonly lasts several weeks facilitating transmission of the
virus to susceptible host by the insect vector.
Cattle are considered to be important reservoir of the virus
Bluetongue
Transmission of Bluetongue??
The disease is transmitted by Culicoides imicola in Africa and Asia.
Venereal transmission through the semen of ram and bull has been reported.
It can also be transmitted by embryo transfer.
Clinical signs of bluetongue??
fever, depression, lip congestion,
oedema, oral mucosa erosion, excessive salivation, tongue lameness,
tortocillis, abortion, and mortality up to 30%.
Diagnosis of Bluetongue??
Clinical signs and postmortem findings are suggestive
Laboratory confirmation requires isolation and identification of the virus or
demonstration of BTV-specific antibodies
Samples: unclotted blood from febrile animals or fresh spleen and lymph
node collected at post mortem
Virus isolation in embryonated egg inoculated intravenously
Antigen detection by ELISA
Serological test for detecting antibodies to BTV serotypes using Complement
fixation test, Agal gel immunodiffusion, indirect immunofluorescence and
competitive ELISA
Control of Bluetongue
attenuated vaccine for protection against virulent virus of homologous
serotype
-Live attenuated vaccine may be teratogenic when used in pregnant
animals during the first half of gestation
-Live attenuated vaccine should not be used during the period of high
vector activity because of the possibility of transferring the vaccine virus to
pregnant animals and the possible genetic reassortment with field virus.
-Live attenuated vaccine virus may revert to virulence
Polyvalent vaccine in regions where more than one serotype is prevalent
Killed adjuvanted vaccine can induce protection but requires booster dose. It
is more expensive to produce.
Recombinant virus-like particle capable of inducing protective immunity have
been produced in insect cells infected with recombinant baculoviruses
expressing BTV protein.
is a reportable, noncontagious, nonzoonotic,
arthropod-borne viral disease of equids that is endemic to sub-Saharan Africa.
African horse sickness (AHS)
African horse sickness (AHS) is a reportable, noncontagious, nonzoonotic,
arthropod-borne viral disease of equids that is endemic to sub-Saharan Africa.
It can be acute, subacute, or subclinical and is characterized by clinical signs
and lesions associated with respiratory and circulatory impairment.
The African horse sickness subgroup is made up of nine serotypes of AHSV and
they are distinguishable by neutralization tests.
Horses are the most susceptible equids, with AHSV infection potentially leading
to case fatality rates of up to 90% in naive populations
African horse sickness(AHS) transmitted by
haematophagous insects
The major vector of African Horse Sickness (AHS)
Culicoides inicola
CLINICAL SIGNS OF AFRICAN HORSE SICKNESS
Fever and mucous membrane congestion are normally the initial clinical
signs, followed a few days later by the supraorbital swelling and
subcutaneous edema of the head and neck.
Four clinical forms of African Horse Sicknesses (AHS )are recognized:
- Peracute pulmonary form - Characterized by depression, nasal discharge
with rapid progression to severe respiratory distress. - Subacute cardiac form - Conjunctivitis, abdominal pain and progressive
dyspnoea - A combination of pulmonary and cardiac features
- Mild or subclassical form termed horse sickness fever observed in zebra
and donkeys
DIAGNOSIS OF AHS
Provisional diagnosis based on clinicopathologic findings
Definitive diagnosis is made by agent identification to rule out differential
diagnoses
EDTA-anticoagulated whole blood or fresh spleen and lung on ice are samples
of choice
Confirmation best by OIE-validated real-time PCR assay
PREVENTION AND CONTROL OF AHS
Currently, there is no specific curative treatment for animals with AHS except for
supportive treatment aimed at cardiac and pulmonary support, rest, and good
general husbandry
Prevention by vaccination remains the mainstay for control in endemic countries
Equine movement control to prevent incursion into free areas and spread within
endemic areas
Vector control and protection of equids
is caused by a virus of the family
Reoviridae, genus Orbivirus; there are 8 or more serotypes and Ibaraki virus is a
member of the EHD virus (EHDV) serogroup (serotype 2).
Epizootic haemorrhagic disease (EHD)
was considered an emerging disease in cattle, and was added to OIE list of
notifiable diseases in May 2008, following outbreaks in four Mediterranean
countries
(EHD) EPIZOOTIC HAEMORRHAGIC DISEASE
demonstrates immunological cross reactivity with the Bluetongue virus
group.
Epizootic Haemorrhagic Disease Virus
(EHD )EPIZOOTIC HAEMORRHAGIC DISEASE can infect most wild and domestic ruminants
Virus is transmitted by biological vectors, usually biting midges of the genus
Culicoides, after an external extrinsic period of 10–14 days
In temperate regions infection is most common in the late summer and autumn
during peak vector population, while infection occurs throughout the year in
tropical regions
CLINICAL SIGNS OF EPIZOOTIC HAEMORRHAGIC DISEASE
The clinical signs of EHD manifest as haemorrhagic disease in deer, but
domestic ruminants may be subclinically infected.
Acute EHD in deer: Fever, weakness, inappetence, excessive salivation,
facial oedema, hyperaemia of the conjunctivae and mucous membranes
of the oral cavity, coronitis stomatitis, and excessive salivation
In prolonged cases, oral ulcers on the dental pad, hard palate, and
tongue may occur. Excessive bleeding occurs in fulminant disease:
bloody diarrhoea, haematuria, dehydration, and death
Ibaraki disease in cattle is characterized by fever, anorexia and difficulty
swallowing
Abortions and stillbirths have also been reported in some epidemics.
Some affected cattle die (up to 10%)
DIAGNOSIS OF EPIZOOTIC HAEMORRHAGIC DISEASE
Virus isolation and detection in;
Whole blood in EDTA and/or heparin (virus isolation), in EDTA or
citrate (PCR)
Spleen
Lungs
Lymph nodes
Liver
Serological tests
PREVENTION AND CONTROL OF EPIZOOTIC HAEMORRHAGIC DISEASE
Other than Ibaraki in cattle, treatment and control is limited for EHDV
Protect animals during loading and transport operations, both by air and
land, through physical barriers, insect repellents and planning of
operations for low vector activity times of the day
Management of Culicoides breeding areas near cattle hosting facilities
Both live modified and inactivated vaccines have been developed to
control Ibaraki disease in cattle in Japan